[14 November 2012]
Products Affected - Description
There are no presentations affected.
Reason for the Shortage
- Merck cannot provide a reason for the shortage.1
- Merck is the sole manufacturer of this combination product.
ProQuad single dose vials (NDC 00006-4999-00), Merck
Estimated Resupply Dates
Merck has ProQuad available.1
Implications for Patient Care
ProQuad is used to simultaneously vaccinate children 12 months to 12 years of age against measles, mumps, rubella, and varicella.2
Do not mix MMR-II and Varivax in the same syringe during this shortage.2
Alternative Agents & Management
Clinicians must use the single component vaccines MMR-II and Varivax during this shortage.1
- Merck, (personal communication). February 26, March 5, May 29, July 10 and 23, 2007; February 11, August 18, 2008; February 11, June 1, June 23, September 1, November 30, 2009; January 21, February 3, March 26, May 4 and 10, June 14, July 26, August 11, September 10, September 22, 2010; March 14, June 7, August 30, October 14, and December 12, 2011; February 8, April 10, June 29, August 29, October 2, and November 14, 2012.
- ProQuad (Measles, Mumps, Rubella, and Varicella Virus Vaccine Live) [product information]. West Point, PA: Merck; 2006, July.
Updated November 14, 2012 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 6, 2007 by Erin R. Fox, PharmD, Drug Information Specialist. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins